Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 28, 2022 17:00 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update

TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and...
May 30, 2022 17:23 ET | Source: Blueberries Medical Corp.

Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update

TORONTO, May 30, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
November 29, 2021 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update

TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
October 04, 2021 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces that its wholly subsidiary Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business to a level that will improve life condition of more than 2.500 patients in Peru

TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
December 04, 2020 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project

TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or...
October 26, 2020 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update

TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
September 08, 2020 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Medical to Webcast Live at VirtualInvestorConferences.com on September 10th

TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE:BBM) (OTCQB: BBRRF) (FRA: 1OA), (the “Company” or "Blueberries"), a Latin American, licensed producer of medicinal cannabis...
July 16, 2020 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
June 08, 2020 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Announces Strategic Partnership with medcann

TORONTO, June 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
April 23, 2020 07:30 ET | Source: Blueberries Medical Corp.

Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production

TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis...

Next Page keyboard_arrow_right